Trellus Health plc (TRLS.L) Research

Trellus Health plc delivers digital health management services for long-term illnesses, primarily serving businesses and insurance companies. The cornerstone of their offerings is TrellusElevate, a secure, proprietary technology platform compliant with HIPAA regulations. This system enables the remote coordination and provision of individualized healthcare via telemedicine. Patients utilizing the platform gain access to dedicated care teams, comprehensive educational materials, and remote monitoring tools. This service specifically addresses inflammatory bowel diseases (IBD), encompassing chronic and incurable conditions like Crohn's Disease and ulcerative colitis. Founded in 2020, Trellus Health plc is headquartered in White Plains, New York.

Market snapshot

Symbol
TRLS.L
Price
$0.12
Day change
-4.00%
Market cap
$249.0K
P/E ratio
-0.04x
52-week range
0.0012-2.336
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 3 months

Peer companies

  • Belluscura plc (BELL.L)
  • EKF Diagnostics Holdings plc (EKF.L)
  • Poolbeg Pharma PLC (POLB.L)
  • Renalytix Plc (RENX.L)
  • Verici Dx plc (VRCI.L)

Open Trellus Health plc (TRLS.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.